Long-term Anticoagulant Therapy with Warfarin and its Risks and Pitfalls in Old Age

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F12%3A00063457" target="_blank" >RIV/00216224:14110/12:00063457 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Long-term Anticoagulant Therapy with Warfarin and its Risks and Pitfalls in Old Age

Popis výsledku v původním jazyce

Warfarin is a frequently used anticoagulant therapy (AT) in clinical practice for elderly patients at risk of thromboembolism (venous or arterial) as well as for those with established thromboembolism. Bleeding is the most common complication of long-term warfarin therapy. The risk of bleeding is directly influenced by intensity of anticoagulant therapy, age, renal insufficiency, and latent disease of the gastrointestinal and genitourinary tracts. Conclusions: Most elderly patients in need of prolongedanticoagulation can be treated safely and effectively with warfarin if treatment includes education, meticulous attention to comorbid illnesses and concomitant drugs, and dose monitoring through a coordinated anticoagulant program.

Název v anglickém jazyce

Long-term Anticoagulant Therapy with Warfarin and its Risks and Pitfalls in Old Age

Popis výsledku anglicky

Warfarin is a frequently used anticoagulant therapy (AT) in clinical practice for elderly patients at risk of thromboembolism (venous or arterial) as well as for those with established thromboembolism. Bleeding is the most common complication of long-term warfarin therapy. The risk of bleeding is directly influenced by intensity of anticoagulant therapy, age, renal insufficiency, and latent disease of the gastrointestinal and genitourinary tracts. Conclusions: Most elderly patients in need of prolongedanticoagulation can be treated safely and effectively with warfarin if treatment includes education, meticulous attention to comorbid illnesses and concomitant drugs, and dose monitoring through a coordinated anticoagulant program.

Druh

O - Ostatní výsledky

CEP obor

FE - Ostatní obory vnitřního lékařství

OECD FORD obor

—

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů